α2-Adrenergic agonist. Prepn: Zeile et al., US 3202660 (1965 to Boehringer, Ing.). Use in shaving soap formulations: eidem, US 3190802 (1965 to Boehringer, Ing.). Pharmacology: Bolme, Fuxe, Eur. J. Pharmacol. 13, 168 (1971). Revised structure: L. M. Jackman, T. Jen, J. Am. Chem. Soc. 97, 2811 (1975). GC determn in plasma: P. O. Edlund, J. Chromatogr. 187, 161 (1980). Activity as α-adrenoceptor agonist: A. G. Roach et al., J. Pharmacol. Exp. Ther. 227, 421 (1983). Symposium on cardiovascular and psychotropic pharmacology and clinical experience: Central Blood Pressure Regulation: The Role of α2-Receptor Stimulation, K. Hayduk, K. B. Bock, Eds. (Steinkopff Verlag, Darmstadt, 1983) 284 pp. Effects in acute smoking withdrawal syndrome: A. H. Glassman et al., Science 226, 864 (1984); in alcoholism withdrawal: Z. Jraidi et al., Therapie 42, 21 (1987). Clinical trial in Tourette's syndrome: J. F. Leckman et al., Neurology 35, 343 (1985); in intractable cancer pain: J. C. Eisenach et al., Pain 61, 391 (1995). Reviews: A. Walland in Pharmacological and Biochemical Properties of Drug Substances vol. 1, M. E. Goldberg, Ed. (Am. Pharm. Assoc., Washington, D.C., 1977) pp 67-107; H. Schmitt, Handb. Exp. Pharmacol. 39, 299-396 (1977); M. C. Houston, Prog. Cardiovasc. Dis. 23, 337-350 (1981). Comprehensive description: M. A. Abounassif et al., Anal. Profiles Drug Subs. Excip. 21, 109-147 (1992). Review of toxicity: D. L. Seger, Clin. Toxicol. 40, 145-155 (2002); of therapeutic potential in perioperative cardiac risk reduction: A. W. Wallace, Curr. Opin. Anaesthesiol. 19, 411-417 (2006).
Antihypertensive; analgesic for neuropathic pain.
α-Adrenergic Agonist; Antidyskinetic; Antihypertensive; Imidazole Derivatives